Xyzal 0.5 mg/ml oral solution أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

xyzal 0.5 mg/ml oral solution

ucb (pharma) ireland limited - levocetirizine dihydrochloride - oral solution - 0.5 milligram(s)/millilitre - piperazine derivatives; levocetirizine

Xyzal 5 mg film-coated tablets أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

xyzal 5 mg film-coated tablets

ucb (pharma) ireland limited - levocetirizine dihydrochloride - film-coated tablet - 5 milligram(s) - piperazine derivatives; levocetirizine

Zirtek 1 mg/ml oral solution أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

zirtek 1 mg/ml oral solution

ucb (pharma) ireland limited - cetirizine dihydrochloride - oral solution - 1 milligram(s)/millilitre - piperazine derivatives; cetirizine

Zirtek 10 mg film-coated tablets أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

zirtek 10 mg film-coated tablets

ucb (pharma) ireland limited - cetirizine hydrochloride - film-coated tablet - 10 milligram(s) - piperazine derivatives; cetirizine

Zirtek 10 mg/ml Oral Drops, Solution أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

zirtek 10 mg/ml oral drops, solution

ucb (pharma) ireland limited - cetirizine dihydrochloride - oral drops, solution - 10 milligram(s)/millilitre - piperazine derivatives; cetirizine

Zirtek Plus Decongestant 5mg/120mg Prolonged Release Tablet أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

zirtek plus decongestant 5mg/120mg prolonged release tablet

ucb (pharma) ireland limited - pseudoephedrine hydrochloride; cetirizine dihydrochloride - prolonged-release tablet - 5mg/120 milligram(s) - sympathomimetics; pseudoephedrine, combinations

NEUPRO rotigotine 3 mg/24 hr transdermal patch sachet أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

neupro rotigotine 3 mg/24 hr transdermal patch sachet

ucb australia pty ltd t/a ucb pharma division of ucb australia - rotigotine, quantity: 6.75 mg - drug delivery system, transdermal - excipient ingredients: povidone; dl-alpha-tocopherol; sodium metabisulfite; ascorbyl palmitate; methylated trimethylated silica; heptane - parkinson's disease, neupro is indicated as monotherapy, or in combination with levodopa, for the treatment of idiopathic parkinson's disease from early stage to advanced disease. restless legs syndrome, neupro is indicated for the symptomatic treatment of moderate to severe idiopathic restless legs syndrome in adults.

NEUPRO rotigotine 1 mg/24 hr transdermal patch sachet أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

neupro rotigotine 1 mg/24 hr transdermal patch sachet

ucb australia pty ltd t/a ucb pharma division of ucb australia - rotigotine, quantity: 2.25 mg - drug delivery system, transdermal - excipient ingredients: dl-alpha-tocopherol; povidone; ascorbyl palmitate; sodium metabisulfite; methylated trimethylated silica; heptane - parkinson's disease, neupro is indicated as monotherapy, or in combination with levodopa, for the treatment of idiopathic parkinson's disease from early stage to advanced disease. restless legs syndrome, neupro is indicated for the symptomatic treatment of moderate to severe idiopathic restless legs syndrome in adults.

Tylex 30mg/500mg capsules المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

tylex 30mg/500mg capsules

ucb pharma ltd - codeine phosphate; paracetamol - oral capsule - 30mg ; 500mg

Tylex 30mg/500mg effervescent tablets المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

tylex 30mg/500mg effervescent tablets

ucb pharma ltd - codeine phosphate; paracetamol - effervescent tablet - 30mg ; 500mg